ARCHIVES

DCT board Okays Recompetition of Clinical Trials Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008